Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 28:12:1388514.
doi: 10.3389/fcell.2024.1388514. eCollection 2024.

Editorial: Emerging insights in glutamate receptor signaling in psychiatric, neurodevelopmental, and neurodegenerative diseases

Affiliations
Editorial

Editorial: Emerging insights in glutamate receptor signaling in psychiatric, neurodevelopmental, and neurodegenerative diseases

Khaled S Abd-Elrahman et al. Front Cell Dev Biol. .
No abstract available

Keywords: brain; disease; glutamate; ionotropic; metabotropic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Emerging insights in glutamate receptor signaling in psychiatric, neurodevelopmental, and neurodegenerative diseases

References

    1. Abd-Elrahman K., Ferguson S. (2021). Noncanonical metabotropic glutamate receptor 5 signaling in alzheimer’s disease. Annu. Rev. Pharmacol. Toxicol. 62, 235–254. 10.1146/ANNUREV-PHARMTOX-021821-091747 - DOI - PubMed
    1. Li S. H., Abd-Elrahman K. S., Ferguson S. S. G. (2022). Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases. Pharmacol. Ther. 239, 108275. 10.1016/J.PHARMTHERA.2022.108275 - DOI - PubMed
    1. Rabeh N., Hajjar B., Maraka J. O., Sammanasunathan A. F., Khan M., Alkhaaldi S. M. I., et al. (2023). Targeting mGluR group III for the treatment of neurodegenerative diseases. Biomed. Pharmacother. 168, 115733. 10.1016/J.BIOPHA.2023.115733 - DOI - PubMed
    1. Ribeiro F. M., Paquet M., Cregan S. P., Ferguson S. S. G. (2010). Group I metabotropic glutamate receptor signalling and its implication in neurological disease. CNS Neurol. Disord. Drug Targets 9, 574–595. 10.2174/187152710793361612 - DOI - PubMed

Publication types

LinkOut - more resources